CN101711807A - Antiphlogistic and antibiotic ointment - Google Patents

Antiphlogistic and antibiotic ointment Download PDF

Info

Publication number
CN101711807A
CN101711807A CN200910102851A CN200910102851A CN101711807A CN 101711807 A CN101711807 A CN 101711807A CN 200910102851 A CN200910102851 A CN 200910102851A CN 200910102851 A CN200910102851 A CN 200910102851A CN 101711807 A CN101711807 A CN 101711807A
Authority
CN
China
Prior art keywords
ointment
parts
vaseline
grams
paraffin oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910102851A
Other languages
Chinese (zh)
Other versions
CN101711807B (en
Inventor
周兴福
刘兵全
杨中伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2009101028516A priority Critical patent/CN101711807B/en
Publication of CN101711807A publication Critical patent/CN101711807A/en
Application granted granted Critical
Publication of CN101711807B publication Critical patent/CN101711807B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an antiphlogistic and antibiotic ointment and belongs to the treatment ointment for external use. The invention aims to provide the ointment for treating dermatonosis such as acne rosacea, acne and the like, burn and scald. The ointment is prepared from the following raw materials in part by weight: 2.5 to 3.5 parts of camphor, 2.5 to 3.5 parts of peppermint, 2.5 to 3.5 parts of Chinese angelica, 3 parts of Chinese gall, 2 parts of honeysuckle flower, 1.5 parts of safflower, 0.7 to 1 part of frankincense, 0.5 to 1 part of golden thread, 0.5 to 0.6 part of borneol, 0.4 to 0.6 part of myrrh, 3 to 4 parts of paraffin oil, 0.7 to 1 part of bee wax, 0.8 to 1.2 parts of methyl salicylate, 0.028 to 0.032 part of miconazole nitrate ointment and 6 to 10 parts of vaseline. The ointment is prepared by melting the vaseline and the bee wax; adding the paraffin oil; blending the mixture; keeping a temperature about 50 DEG C; adding powders of the Chinese medicinal plants; uniformly stirring the mixture, and then adding the western medicaments; and uniformly stirring and cooling the mixture. The ointment has obvious curative effect and is a good medicament for treating diseases such as the acne rosacea, the acne, the burn and scald and the like.

Description

Anti-inflammation antibacterial medicinal ointment
Technical field: the present invention relates to a kind of ointment, relate in particular to a kind of anti-inflammation antibacterial medicinal ointment for the treatment of dermatosiss such as acne rosacea, acne and burn and scald.
Background technology: acne rosacea is a kind of chronic inflammatory disease dermatosis, and skin lesion is sent out in mid-face well.Cardinal symptom has the nose flushing, and is facial greasy shinny, continues with pruritus, scorching hot and pain.Red little pimple, papulovesicle and pustule appear in early stage nose, and nose capillary congestion is serious, see through skin and can see dendroid blood capillary branch, and final nose become loose, the coarse injustice of outward appearance influence attractive in appearance.Acne is an adolescence common skin disease, is mainly in buccal, forehead, also visible thoracic dorsal.The initial stage erythra is the syringe needle size conical pimple consistent with hair follicle, and can there be blackhead on the top, can squeeze out the yellow-white granulated slag.The erythra dispersed and distributed, the secondary infection of part patient's erythra, then pimple is wound with blush, the visible pustule in top, even inflammatory tubercle, the cyst of Semen phaseoli radiati size are arranged, and being kermesinus, the back of disappearing forms atrophic scar or pimple.
Medical science is thought: acne rosacea causes because of mite infection that mainly bad dietary habit and oily skin also is one of inducement simultaneously.At present, the external used medicine of treatment acne rosacea mainly contains sulphur ointment, metronidazole ointment etc., and oral drugs mainly contain metronidazole, tinidazole, tetracycline etc.; But these medicines not only weak curative effect, long, the easy recurrence course of treatment but also side effect are also bigger.Acne is infected and is influenced due to the smegma by skin, if the smegma thing mixes with the skin dead cell and will stop up hair follicle, antibacterial can be in this quick breeding, and at dermal sites generation pustule, goose pimples.At present, mainly adopt medicine for external use treatment acnes such as salicylic acid, sulfur, acetone, but these curative effect of medication are relatively poor, can only the respite symptom.
Summary of the invention: at the above-mentioned defective that exists in the prior art, the present invention aims to provide a kind of short treating period, instant effect, good effect, to dermatosis such as acne rosacea, acne and hinder and scald the anti-inflammation antibacterial medicinal ointment that significant curative effect is arranged.
To achieve these goals, the present invention is made by the raw material of following weight portion: Camphora 2.5~3.5, Herba Menthae 2.5~3.5, Radix Angelicae Sinensis 2.5~3.5, Galla Chinensis 3, Flos Lonicerae 2, Flos Carthami 1.5, Olibanum 0.7~1, Rhizoma Coptidis 0.5~1, Borneolum Syntheticum 0.5~0.6, Myrrha 0.4~0.6, paraffin oil 3~4, Cera Flava 0.7~1, salicylic acid potassium ester 0.8~1.2, miconazole nitrate ointment 0.028~0.032, vaseline 6~10, and preparation method is as follows:
1) it is standby the Chinese crude drug of respectively distinguishing the flavor of in the above-mentioned raw materials to be made powder;
2) with the fusing of the vaseline in the above-mentioned raw materials, Cera Flava Hybrid Heating, add the paraffin oil in the above-mentioned raw materials then, stir mixed oil liquid, temperature remains on about 50 ℃;
3) the above-mentioned Chinese drugs powder of respectively distinguishing the flavor of is added in the above-mentioned mixed oil liquid stir, add the Western medicine in the above-mentioned raw materials then, stir, cool off.
The preferred technical solution of the present invention is: Camphora 3, Herba Menthae 3, Radix Angelicae Sinensis 3, Galla Chinensis 3, Flos Lonicerae 2, Flos Carthami 1.5, Olibanum 0.8, Rhizoma Coptidis 0.81, Borneolum Syntheticum 0.5, Myrrha 0.5, paraffin oil 3, Cera Flava 0.8, salicylic acid potassium ester 0.9, miconazole nitrate ointment 0.03, vaseline 8.
In technique scheme, Camphora has gentle stimulation and antisepsis to skin, and parasite killing, analgesia, itching relieving effect are arranged, and can treat diseases such as tinea alba, ecthyma, scrofula skin ulcer are festered, sore due to scald and burn; The alcoholic solution of Herba Menthae has anticorrosion and antibacterial action, can treat diseases such as aphtha, toothache, skin ulcer scabies, urticaria; Radix Angelicae Sinensis has the effect of benefiting blood and regulating blood circulation, can treat diseases such as ulcer sores, injury from falling down, the bold and vigorous baked wheaten cake of soup skin ulcer; Tannic acid in the Galla Chinensis has precipitation to protein, its tissue protein promptly is solidified behind skin, mucosa contact tannic acid, form one deck tunicle and restrain, the oppressed contraction of little blood vessel simultaneously, blood clotting and stopping blooding, the protein of glandular cell is solidified and causes that secretion suppresses, and forms the mucosa drying; Therefore Galla Chinensis has convergence and antibacterial action; Galla Chinensis have astringe the lung, astringing intestine to stop diarrhea, detoxifcation, hemostatic effect, can treat diseases such as toxic swelling, furuncle, all pyretic toxicity bleb skin ulcers, the open sore part are not received, occipitalia furuncle and phyma; Flos Lonicerae has the effect of heat-clearing and toxic substances removing, can treat diseases such as epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle and ulcer, all toxic swellings, scabies, furuncle inguinal bubo; Flos Carthami has vasoconstrictive, the effect of blood stasis removing analgesic, can treat diseases such as reaching variola warm blood difficulty goes out, the stasis of speckle rash does not disappear, all rednesses, decubital ulcer; Olibanum has regulating qi and activating blood, analgesic therapy, chases after the effect of poison, can treat diseases such as vim and vigour stagnate, carbuncle pyogenic infections from tumour or sore; Rhizoma Coptidis has pathogenic fire purging, dampness, detoxifcation, parasiticidal effect, diseases such as row pyretic toxicity, typhoid fever, aphtha, skin sore, pustule ulcer, eczema, skin infection and the burning hot wound of soup in the time of can treating; The effect of Borneolum Syntheticum is similar to Camphora, and pain relieving and antisepsis are arranged during topical application, and mucosa, subcutaneous tissue all easily absorb, and the effect of reducing swelling and alleviating pain is arranged, and can treat diseases such as carbuncle, hemorrhoid burn and scald; Myrrha has inhibitory action in various degree to multiple pathomycetes such as trichophyton, concentric trichophyton, oidium schoenleiniis, and the effect of diffusing blood blood stasis removing, subduing swelling and relieving pain is arranged, and can treat diseases such as incised wound, ulcer sore pain; Paraffin oil has astriction.
Compared with the prior art, the present invention is owing to adopted technique scheme, Chinese medicine and western medicine combination, treating both the principal and secondary aspects of a disease; Bactericidal antiphlogistic, heat-clearing and toxic substances removing, analgesic effect are obvious, have advantages such as short treating period, instant effect, good effect, and do not recur after the rehabilitation, no sequel, do not stay scar.Through the clinical verification of more than ten years, people surplus ointment of the present invention has cured 4000, curative effect is very remarkable; Wherein, be 98% to acne rosacea, acne cure rate, the cure rate of burn and scald is 96%.
Ointment of the present invention belongs to medicine for external use, forbids taking orally, is prohibited from entering in eye, nose, the mouth anemia of pregnant woman's forbidding.Only need during use ointment is applied in the affected part, 1~2 time on the one, can fully recover in 7~10 days; If irritation or anaphylaxis occur, get final product with clear water is clean, have no side effect.
The specific embodiment: the invention will be further described below in conjunction with specific embodiment:
Embodiment 1, with Camphora 2.5 gram, Herba Menthae 2.5 grams, Radix Angelicae Sinensis 2.5 grams, Galla Chinensis 3 grams, Flos Lonicerae 2 grams, Flos Carthami 1.5 grams, Olibanum 0.7 gram, Rhizoma Coptidis 0.5 gram, Borneolum Syntheticum 0.5 gram, that Myrrha 0.4 is restrained powdered is standby, vaseline 6 grams, Cera Flava 0.7 gram are mixed the post-heating fusing, add 3 gram paraffin oil then, stir mixed oil liquid, temperature remains on about 50 ℃; The above-mentioned standby Chinese drugs powder of respectively distinguishing the flavor of sneaked in the above-mentioned mixed oil liquid stir, add 0.8 gram salicylic acid potassium ester at last again, 0.028 gram miconazole nitrate ointment stirs, cooling gets final product.
Embodiment 2, and preparation method is with embodiment 1; Wherein each raw material is: Camphora 3.5, Herba Menthae 3.5, Radix Angelicae Sinensis 3.5, Galla Chinensis 3, Flos Lonicerae 2 grams, Flos Carthami 1.5 grams, Olibanum 1 gram, Rhizoma Coptidis 1 gram, Borneolum Syntheticum 0.6 gram, Myrrha 0.6 gram, paraffin oil 4 grams, Cera Flava 1 gram, salicylic acid potassium ester 1.2 grams, miconazole nitrate ointment 0.032 gram, vaseline 10 grams.
Embodiment 3, and preparation method is with embodiment 1; Wherein each raw material is: Camphora 2.5 grams, Herba Menthae 3.5 grams, Radix Angelicae Sinensis 2.5 grams, Galla Chinensis 3 grams, Flos Lonicerae 2 grams, Flos Carthami 1.5 grams, Olibanum 1 gram, Rhizoma Coptidis 0.5 gram, Borneolum Syntheticum 0.6 gram, Myrrha 0.4 gram, paraffin oil 4 grams, Cera Flava 0.7 gram, salicylic acid potassium ester 1.2 grams, miconazole nitrate ointment 0.028 gram, vaseline 10 grams.
Embodiment 4, and preparation method is with embodiment 1; Wherein each raw material is: Camphora 3.5 grams, Herba Menthae 2.5 grams, Radix Angelicae Sinensis 3.5 grams, Galla Chinensis 3 grams, Flos Lonicerae 2 grams, Flos Carthami 1.5 grams, Olibanum 0.7 gram, Rhizoma Coptidis 1 gram, Borneolum Syntheticum 0.5 gram, Myrrha 0.6 gram, paraffin oil 3 grams, Cera Flava 1 gram, salicylic acid potassium ester 0.8 gram, miconazole nitrate ointment 0.032 gram, vaseline 6 grams.
Embodiment 5, and preparation method is with embodiment 1; Wherein each raw material is: Camphora 3 grams, Herba Menthae 3 grams, Radix Angelicae Sinensis 3 grams, Galla Chinensis 3 grams, Flos Lonicerae 2 grams, Flos Carthami 1.5 grams, Olibanum 0.8 gram, Rhizoma Coptidis 0.81 gram, Borneolum Syntheticum 0.5 gram, Myrrha 0.5 gram, paraffin oil 3 grams, Cera Flava 0.8 gram, salicylic acid potassium ester 0.9 gram, miconazole nitrate ointment 0.03 gram, vaseline 8 grams.

Claims (2)

1. anti-inflammation antibacterial medicinal ointment, it is characterized in that making by the raw material of following weight portion: Camphora 2.5~3.5, Herba Menthae 2.5~3.5, Radix Angelicae Sinensis 2.5~3.5, Galla Chinensis 3, Flos Lonicerae 2, Flos Carthami 1.5, Olibanum 0.7~1, Rhizoma Coptidis 0.5~1, Borneolum Syntheticum 0.5~0.6, Myrrha 0.4~0.6, paraffin oil 3~4, Cera Flava 0.7~1, salicylic acid potassium ester 0.8~1.2, miconazole nitrate ointment 0.028~0.032, vaseline 6~10, preparation method is as follows:
1) it is standby the Chinese crude drug of respectively distinguishing the flavor of in the above-mentioned raw materials to be made powder;
2) with the fusing of the vaseline in the above-mentioned raw materials, Cera Flava Hybrid Heating, add the paraffin oil in the above-mentioned raw materials then, stir mixed oil liquid, temperature remains on about 50 ℃;
3) the above-mentioned Chinese drugs powder of respectively distinguishing the flavor of is added in the above-mentioned mixed oil liquid stir, add the Western medicine in the above-mentioned raw materials then, stir, cool off.
2. anti-inflammation antibacterial medicinal ointment according to claim 1 is characterized in that: Camphora 3, Herba Menthae 3, Radix Angelicae Sinensis 3, Galla Chinensis 3, Flos Lonicerae 2, Flos Carthami 1.5, Olibanum 0.8, Rhizoma Coptidis 0.81, Borneolum Syntheticum 0.5, Myrrha 0.5, paraffin oil 3, Cera Flava 0.8, salicylic acid potassium ester 0.9, miconazole nitrate 0.03, vaseline 8.
CN2009101028516A 2009-11-16 2009-11-16 Antiphlogistic and antibiotic ointment Expired - Fee Related CN101711807B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009101028516A CN101711807B (en) 2009-11-16 2009-11-16 Antiphlogistic and antibiotic ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009101028516A CN101711807B (en) 2009-11-16 2009-11-16 Antiphlogistic and antibiotic ointment

Publications (2)

Publication Number Publication Date
CN101711807A true CN101711807A (en) 2010-05-26
CN101711807B CN101711807B (en) 2012-02-01

Family

ID=42416054

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009101028516A Expired - Fee Related CN101711807B (en) 2009-11-16 2009-11-16 Antiphlogistic and antibiotic ointment

Country Status (1)

Country Link
CN (1) CN101711807B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103961406A (en) * 2014-04-21 2014-08-06 潘景山 Skin protection cream and preparation method thereof
CN106236862A (en) * 2016-08-24 2016-12-21 李洪芳 A kind of medicine treating eczema and preparation method thereof
CN108524734A (en) * 2018-05-28 2018-09-14 陈雨薇 A kind of ointment for scald and preparation method thereof
CN110711231A (en) * 2019-11-28 2020-01-21 张志杰 Pharmaceutical composition and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103961406A (en) * 2014-04-21 2014-08-06 潘景山 Skin protection cream and preparation method thereof
CN106236862A (en) * 2016-08-24 2016-12-21 李洪芳 A kind of medicine treating eczema and preparation method thereof
CN108524734A (en) * 2018-05-28 2018-09-14 陈雨薇 A kind of ointment for scald and preparation method thereof
CN110711231A (en) * 2019-11-28 2020-01-21 张志杰 Pharmaceutical composition and preparation method thereof

Also Published As

Publication number Publication date
CN101711807B (en) 2012-02-01

Similar Documents

Publication Publication Date Title
CN103860591B (en) A kind of come off for hemorrhoid after the external Miao medicine and preparation method thereof of promoting tissue regeneration and ulcer healing
CN105535715A (en) Traditional Chinese medicine skin-wash liquid for treating hot and damp eczema
CN104288504A (en) Traditional Chinese medicinal ointment preparation for treating burn and scalds and preparation method thereof
CN101711807B (en) Antiphlogistic and antibiotic ointment
CN101703651B (en) Medicament for treating diabetic gangrene
CN103405698A (en) Traditional Chinese medicine liniment for treating acnes and preparation method thereof
CN103611084B (en) Ointment for treating sore and furuncle and preparation method thereof
CN103494962B (en) Traditional Chinese medicine composition capable of clearing heat and detoxifying
CN102784316B (en) Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method
CN105943666B (en) Composition for nursing sensitive skin of infant and preparation method thereof
CN101919969B (en) Traditional Chinese medicine oral liquid preparation for treating hemorrhoids
CN102920941A (en) Plaster for treating red and swollen sore and anonymous gall and preparation method of plaster
CN104367906A (en) Medicine for treating burns and scalds, acne rosacea and acnes and preparation method thereof
CN100556425C (en) A kind of Chinese medicine unguentum of analgetic, hemostatic repercussive and sore-arresting functions
CN104474528A (en) Medicine used for drainage detoxification
CN100355437C (en) Medicine for treating scald and burn and preparing method
CN102258602B (en) Chinese medicinal composition for treating rheumatism and rheumatoid and preparation method thereof
CN101474329B (en) Moschus skin recovery paste for treating damaged skin
CN101342344A (en) Chinese medicine for treating piles
CN104474405A (en) Traditional Chinese medicine composition for treating chloasma
CN108686080A (en) A kind of band bed sore ointment and preparation method thereof
CN102697928B (en) Preparation method for medicine composition for treating traumatic injury
CN103816381A (en) Medicine for treating traumatic injuries and preparation method thereof
CN103070994B (en) Plaster for treating cervical and lumbar spondylosis
CN106668295A (en) Externally-used medicine for treating psoriasis, and preparation method of externally-used medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120201

Termination date: 20121116